293 related articles for article (PubMed ID: 24652288)
1. Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation.
Gurunathan S; Winkles JA; Ghosh S; Hayden MS
J Biol Chem; 2014 May; 289(19):12976-88. PubMed ID: 24652288
[TBL] [Abstract][Full Text] [Related]
2. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
[TBL] [Abstract][Full Text] [Related]
3. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
[TBL] [Abstract][Full Text] [Related]
4. The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.
Haile WB; Echeverry R; Wu J; Yepes M
J Cereb Blood Flow Metab; 2010 Jun; 30(6):1147-56. PubMed ID: 20068578
[TBL] [Abstract][Full Text] [Related]
5. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.
Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972
[TBL] [Abstract][Full Text] [Related]
6. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
[TBL] [Abstract][Full Text] [Related]
7. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
Brown SA; Cheng E; Williams MS; Winkles JA
PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death.
Haile WB; Echeverry R; Wu F; Guzman J; An J; Wu J; Yepes M
Neuroscience; 2010 Dec; 171(4):1256-64. PubMed ID: 20955770
[TBL] [Abstract][Full Text] [Related]
9. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
[TBL] [Abstract][Full Text] [Related]
10. TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.
Polek TC; Talpaz M; Darnay BG; Spivak-Kroizman T
J Biol Chem; 2003 Aug; 278(34):32317-23. PubMed ID: 12794080
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.
Salzmann S; Seher A; Trebing J; Weisenberger D; Rosenthal A; Siegmund D; Wajant H
J Biol Chem; 2013 May; 288(19):13455-66. PubMed ID: 23532848
[TBL] [Abstract][Full Text] [Related]
12. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system.
Echeverry R; Wu F; Haile WB; Wu J; Yepes M
J Neuroinflammation; 2012 Mar; 9():45. PubMed ID: 22394384
[TBL] [Abstract][Full Text] [Related]
13. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.
Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W
PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193
[TBL] [Abstract][Full Text] [Related]
14. Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14).
Fick A; Lang I; Schäfer V; Seher A; Trebing J; Weisenberger D; Wajant H
J Biol Chem; 2012 Jan; 287(1):484-495. PubMed ID: 22081603
[TBL] [Abstract][Full Text] [Related]
15. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
[TBL] [Abstract][Full Text] [Related]
16. Intraovarian tumor necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible-14 ligand-receptor system limits ovarian preovulatory follicles from excessive luteinization.
De A; Park JI; Kawamura K; Chen R; Klein C; Rauch R; Mulders SM; Sollewijn Gelpke MD; Hsueh AJ
Mol Endocrinol; 2006 Oct; 20(10):2528-38. PubMed ID: 16762976
[TBL] [Abstract][Full Text] [Related]
17. The Src homology 3 domain-containing guanine nucleotide exchange factor is overexpressed in high-grade gliomas and promotes tumor necrosis factor-like weak inducer of apoptosis-fibroblast growth factor-inducible 14-induced cell migration and invasion via tumor necrosis factor receptor-associated factor 2.
Fortin Ensign SP; Mathews IT; Eschbacher JM; Loftus JC; Symons MH; Tran NL
J Biol Chem; 2013 Jul; 288(30):21887-97. PubMed ID: 23775076
[TBL] [Abstract][Full Text] [Related]
18. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha.
Vince JE; Chau D; Callus B; Wong WW; Hawkins CJ; Schneider P; McKinlay M; Benetatos CA; Condon SM; Chunduru SK; Yeoh G; Brink R; Vaux DL; Silke J
J Cell Biol; 2008 Jul; 182(1):171-84. PubMed ID: 18606850
[TBL] [Abstract][Full Text] [Related]
19. The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson's disease.
Mustafa S; Martin HL; Burkly L; Costa A; Martins ML; Schwaninger M; Teismann P
Neuroscience; 2016 Apr; 319():116-22. PubMed ID: 26808775
[TBL] [Abstract][Full Text] [Related]
20. The TWEAK-Fn14 system as a potential drug target.
Wajant H
Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
